Andere Kunden interessierten sich auch für
![Combination Studies With The Vascular Disrupting Agent CA4P]( "Combination Studies With The Vascular Disrupting Agent CA4P")
Combination Studies With The Vascular Disrupting Agent CA4P51,99 €![Rosuvastatin versus a combination of Atorvastatin and Ezetimibe]( "Rosuvastatin versus a combination of Atorvastatin and Ezetimibe")
Rosuvastatin versus a combination of Atorvastatin and Ezetimibe44,99 €![Novel Combination Therapies for Prostate Cancer Treatment]( "Novel Combination Therapies for Prostate Cancer Treatment")
Novel Combination Therapies for Prostate Cancer Treatment23,99 €![Synergy Test of Theaflavin in Combination with Antibacterial Drugs]( "Synergy Test of Theaflavin in Combination with Antibacterial Drugs")
Synergy Test of Theaflavin in Combination with Antibacterial Drugs36,99 €![FEATURES OF THE COURSE OF CHD IN COMBINATION WITH COPD]( "FEATURES OF THE COURSE OF CHD IN COMBINATION WITH COPD")
FEATURES OF THE COURSE OF CHD IN COMBINATION WITH COPD44,99 €![Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging]( "Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging")
Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging207,99 €![COMBINATION PHYSIOTHERAPY REGIMENS IN MANAGING LOW BACK PAIN]( "COMBINATION PHYSIOTHERAPY REGIMENS IN MANAGING LOW BACK PAIN")
COMBINATION PHYSIOTHERAPY REGIMENS IN MANAGING LOW BACK PAIN38,99 €
The aim of this research work is to the determination of photolytic degradation of the Tenaxit®, product of Incepta Pharmaceuticals Ltd., Bangladesh. Each tablet contains flupentixol INN 0.5 mg (as di-hydrochloride) and melitracen INN 10 mg (as di-hydrochloride). By conducting various type of physical, chemical and instrumental tests were done to determine whether the product is photo sensitive or not in various conditions (control, direct sunlight, normal light in the room, 25watt and 40watt light condition). Physical tests were performed according to the specification of official pharmacopoeia for evaluation of hardness, thickness, weight variation, friability of the Tenaxit® tablets from same batch. Finally, the sample was prepared for the UV-Spectroscopy measurement and absorbance of prepared sample was measured. It was observed that the potency of Tenaxit® was decreased gradually in various conditions after light exposure. So it can be said that the Tenaxit® containing combination of Flupentixol hydrochloride and Melitracen hydrochloride is light sensitive and exposing it to the light and radiation may hamper the content uniformity of the tablet.